[Letter: Porphyria cutanea tarda: normalization of porphyrin-excretion following treatment with p-amino-benzoic acid (Potaba) (author's transl)].
Two patients with porphyria cutanea tarda were treated with p-amino-benzoic acid (Potaba) (3x4g/day). Normalization of porphyrin-excretion was observed after three respectively 45 days of treatment. Furthermore no influence of the excretion of porphyrin precursors (porphobilinogen or delta-amino-levulinic acid) were noticed. Also, no side effects of this treatment were found.
D000328:Adult; D062365:Aminobenzoates / Q000627:therapeutic use*; D000622:Aminolevulinic Acid / Q000652:urine; D005260:Female; D006801:Humans; D008875:Middle Aged; D011162:Porphobilinogen / Q000652:urine; D011164:Porphyrias / Q000188:drug therapy* / Q000652:urine; D011166:Porphyrins / Q000652:urine
D062365:Aminobenzoates; D011166:Porphyrins; D011162:Porphobilinogen; D000622:Aminolevulinic Acid
Porphyria cutanes tarda: Normalisierung der Porphyrin-Ausscheidung unter p-Aminobenzoat (Potaba)